Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Corvus Pharmaceuticals Inc sell me8

Start price
€5.55
20.09.21 / 0%
Target price
€4.00
20.09.22
Performance (%)
-13.87%
End price
€4.78
30.09.21
Summary
This prediction ended on 30.09.21 with a price of €4.78. The price of Corvus Pharmaceuticals Inc decreased from the start of the prediction. Compared to the start price this resulted in a performance of -13.87%. This prediction was marked as speculative and is excluded from me8's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Corvus Pharmaceuticals Inc -8.671% -8.671% 176.417%
iShares Core DAX® 1.883% 5.122% 21.667%
iShares Nasdaq 100 0.125% 2.574% 45.951%
iShares Nikkei 225® -0.201% 4.341% 28.806%
iShares S&P 500 0.728% 4.141% 34.630%

According to me8 what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?

Pros
Good culture
Cons
Probably not worthwhile Investment
Below average Management
Little innovation

Comments by me8 for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren

Sell Corvus Pharmaceuticals Inc

Prediction Sell
Perf. (%) -13.87%
Target price 4.000
Change
Ends at 20.09.22

Kursziel gesetzt auf 4,0

In the thread Trading Corvus Pharmaceuticals Inc
Prediction Sell
Perf. (%) -13.87%
Target price 4.000
Change
Ends at 20.09.22

Sell beendet